{
    "clinical_study": {
        "@rank": "63711", 
        "arm_group": {
            "arm_group_label": "Renal denervation", 
            "arm_group_type": "Other", 
            "description": "Patients will be treated with the OneShot ablation system"
        }, 
        "brief_summary": {
            "textblock": "This is a multi-center, prospective registry designed to monitor the outcomes of renal\n      denervation with the OneShot Device in a real-world patient population."
        }, 
        "brief_title": "OneShot Renal Denervation Registry", 
        "completion_date": {
            "#text": "October 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypertension", 
            "Heart Failure", 
            "Diabetes Mellitus", 
            "Sleep Apnea"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Diabetes Mellitus", 
                "Heart Failure", 
                "Hypertension", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient is an acceptable candidate for renal denervation based upon the Instructions\n             for Use.\n\n          -  Patient is \u2265 18 years old.\n\n          -  Patient provided written informed consent.\n\n        Exclusion Criteria:\n\n          -  Patients who are pregnant, nursing, or planning to become pregnant.\n\n          -  Patients who have only one functioning kidney.\n\n          -  Allergy to contrast or known hypersensitivity to device materials\n\n          -  Patients with renal arteries < 4 mm in diameter.\n\n          -  Patients whose life expectancy is less than the planned period of study involvement."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01844037", 
            "org_study_id": "CP1002"
        }, 
        "intervention": {
            "arm_group_label": "Renal denervation", 
            "description": "Renal denervation", 
            "intervention_name": "OneShot Ablation System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Milano", 
                    "country": "Italy"
                }, 
                "name": "Hospital San Raffaele"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "1", 
        "official_title": "Renal Denervation Using the OneShot Ablation System", 
        "overall_contact": {
            "email": "Karen.krygier@covidien.com", 
            "last_name": "Karen Krygier"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in office systolic blood pressure (SBP) from baseline to 6 months", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01844037"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Acute procedural safety, defined as freedom from renal artery dissection or perforation requiring intervention.", 
                "safety_issue": "Yes", 
                "time_frame": "One Week"
            }, 
            {
                "measure": "Change in office diastolic blood pressure (DBP)", 
                "safety_issue": "No", 
                "time_frame": "6, 12, 24, and 36 months post procedure"
            }, 
            {
                "measure": "Change in office SBP", 
                "safety_issue": "No", 
                "time_frame": "6, 12, 24, and 36 months post procedure"
            }
        ], 
        "source": "Covidien", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Covidien", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}